CDH2 and breast cancer: N-cadherin (CDH2), a direct target of miR-145, is a cell-cell adhesion molecule that contributes to the invasive/metastatic phenotype in many cancers such as gastric cancer, breast cancer, and lung cancer (Lei et al., 2017; Mo et al., 2017; Ye et al., 2018).